You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
VIEW TAGS
Articles tagged ‘type 2 diabetes’
August 2011
Br J Cardiol 2011;18:167–69
Drugs for diabetes: part 6 GLP-1 receptor agonists
The glucagon-like peptide-1 (GLP-1) receptor agonists are a new class of injected drugs for the treatment of type 2 diabetes. They mimic the action of...
June 2011
Br J Cardiol 2011;18:130–2
Drugs for diabetes: part 5 DPP-4 inhibitors
The dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral drugs for the treatment of type 2 diabetes. They inhibit the breakdown of glucagon-like...
April 2011
Br J Cardiol 2011;18:78−81
Drugs for diabetes: part 4 acarbose
Acarbose is an alpha-glucosidase inhibitor acting in the gastrointestinal tract producing modest reductions in postprandial hyperglycaemia, with negligible risk of hypoglycaemia and weight gain. In...
November 2010
Br J Cardiol 2010;17:279–82
Drugs for diabetes: part 2 sulphonylureas
Sulphonylureas are well established in the treatment of type 2 diabetes mellitus. They are effective in improving glycaemic control and preventing microvascular complications. Side effects...
September 2010
Br J Cardiol 2010;17:231–4
Drugs for diabetes: part 1 metformin
Metformin is one of the oldest oral treatments to reduce hyperglycaemia in people with diabetes. Gastrointestinal side effects are common, and metformin should be used...
November 2009
Br J Cardiol 2009;16:269-71
CHD risk is being overestimated in diabetes
The Framingham and UKPDS (United Kingdom Prospective Diabetes Study) risk equations overestimate the probability of cardiovascular events in people with type 2 diabetes, according to...
July 2009
Br J Cardiol 2009;16:163-6
New NICE guidelines on new treatments for type 2 diabetes
The National Institute for Health and Clinical Excellence (NICE) has issued a new guidance on the use of several newer agents for blood glucose control...
November 2008
Br J Cardiol 2008;15:301
News from the EASD
This year’s European Association for the Study of Diabetes meeting took place in Rome, Italy. Rhonda Siddall reports on the highlights of the meeting, which...
January 2007
Br J Cardiol 2007;14:57-60
‘Tidal wave’ of obesity and type 2 diabetes predicted to dominate CVD practice
The management of the ‘tidal wave’ of obesity and type 2 diabetes that is expected to hit the UK over the next 10 years was...